Xadago

Xadago (safinamide) is an oral medication used alongside levodopa/carbidopa to manage Parkinson’s disease symptoms like motor fluctuations. It belongs to the MAO-B inhibitor class, supporting smoother movement and daily function. This overview covers key details for safe, informed use.

Xadago (safinamide) is primarily used to treat Parkinson’s disease, particularly to reduce wearing-off episodes in patients already taking levodopa/carbidopa. It helps stabilize motor symptoms such as tremors, stiffness, and slowed movement. Patients often use it to improve daily activities and maintain independence. It is not a standalone treatment but works as an adjunct therapy.

Xadago (safinamide) may help improve movement control and reduce unpredictable off periods during the day. Some users report feeling steadier and more balanced when taking it regularly. It is designed to support consistent symptom management without causing immediate sedation. Effects can vary by individual and may take time to become noticeable.

Keep Xadago (safinamide) in a cool, dry place away from direct sunlight and out of reach of children. Store at room temperature as directed on the packaging. Avoid crushing or splitting tablets unless advised by a healthcare provider. Discard unused medication properly according to local guidelines.

Xadago (safinamide) may interact with other MAO inhibitors, certain antidepressants, or opioid medications. Avoid combining it with foods high in tyramine, such as aged cheeses or cured meats, to reduce the risk of elevated blood pressure. Always inform your pharmacist or doctor about all medications and supplements you are taking before starting Xadago.